GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » Cyclically Adjusted Price-to-FCF

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF Chart

Tonghua Golden-horse Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF falls into.



Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tonghua Golden-horse Pharmaceutical Industry Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.016/115.2271*115.2271
=-0.016

Current CPI (Mar. 2024) = 115.2271.

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.042 98.200 -0.049
201409 -0.124 98.900 -0.144
201412 -0.095 99.000 -0.111
201503 -0.048 99.900 -0.055
201506 -0.148 99.500 -0.171
201509 -0.029 100.500 -0.033
201512 -0.058 100.600 -0.066
201603 -0.025 102.200 -0.028
201606 -0.248 101.400 -0.282
201609 0.067 102.400 0.075
201612 0.087 102.600 0.098
201703 -0.086 103.200 -0.096
201706 -0.030 103.100 -0.034
201709 0.006 104.100 0.007
201712 0.016 104.500 0.018
201803 0.035 105.300 0.038
201806 0.071 104.900 0.078
201809 0.106 106.600 0.115
201812 -0.114 106.500 -0.123
201903 -0.101 107.700 -0.108
201906 0.109 107.700 0.117
201909 0.008 109.800 0.008
201912 -0.007 111.200 -0.007
202003 0.026 112.300 0.027
202006 -0.027 110.400 -0.028
202009 0.007 111.700 0.007
202012 0.056 111.500 0.058
202103 -0.008 112.662 -0.008
202106 0.005 111.769 0.005
202109 0.032 112.215 0.033
202112 0.136 113.108 0.139
202203 0.000 114.335 0.000
202206 0.051 114.558 0.051
202209 0.024 115.339 0.024
202212 0.091 115.116 0.091
202303 0.001 115.116 0.001
202306 0.030 114.558 0.030
202309 0.040 115.339 0.040
202312 0.028 114.781 0.028
202403 -0.016 115.227 -0.016

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tonghua Golden-horse Pharmaceutical Industry Co  (SZSE:000766) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Executives
Wei Ying Jie Director
Zan Bao Shi Director
Wu Cheng Yu Directors, executives
Zhang De Ju Supervisors
Li Ju Supervisors
Feng Ran Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines